LungVITamin D and OmegA-3 Trial (lungVITAL) (lungVITAL)
LungVITamin D and OmegA-3 Trial
Sponsor: Brigham and Women's Hospital
A NA clinical study on Asthma and COPD, this trial is ongoing. The trial is conducted by Brigham and Women's Hospital and has accumulated 12 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Mar 2025 — Present [monthly]
Active Not Recruiting NA
-
Sep 2024 — Mar 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Jan 2022 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Sep 2021 — Jan 2022 [monthly]
Active Not Recruiting NA
▶ Show 7 earlier versions
-
Apr 2021 — Sep 2021 [monthly]
Active Not Recruiting NA
-
Mar 2021 — Apr 2021 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting NA
-
Jun 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Feb 2019 — Jun 2020 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Feb 2019 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
First recorded
Jul 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Brigham and Women's Hospital
- Harvard School of Public Health (HSPH)
For direct contact, visit the study record on ClinicalTrials.gov .